Janchor Partners

Asia, Hong Kong Island, Hong Kong, Central

Description

Janchor Partners is a long‐term industrialist investor, partnering with companies that have superior business models.

Investor Profile

Janchor Partners has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series D, Series C, Private Equity rounds (top funding stages).
Majority of deals are located in China, United States, India.
Strong thematic focus on Health Care, Pharmaceutical, Biotechnology.

Stage Focus

Series D (33%)
Series C (33%)
Private Equity (17%)
Series A (17%)

Country Focus

China (67%)
United States (17%)
India (17%)

Industry Focus

Health Care
Pharmaceutical
Biotechnology
Therapeutics
Medical
Biopharma
Credit Cards
Finance
Financial Services
Fintech

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Janchor Partners frequently co-invest with?

OrbiMed

North America, New York, United States, New York

Co-Investments: 4

CICC

Asia, Beijing, China, Beijing

Co-Investments: 1

Greater Bay Area Homeland Development Fund

Asia, Hong Kong Island, Hong Kong, Hong Kong

Co-Investments: 1

Hudson Bay Capital Management

Hudson Bay Capital Management

North America, New York, United States, New York

Co-Investments: 2

Lake Bleu Capital

Lake Bleu Capital

Asia, Hong Kong Island, Hong Kong, Hong Kong

Co-Investments: 3

Octagon Capital Advisors

Octagon Capital Advisors

North America, New York, United States, New York

Co-Investments: 2

Qiming Venture Partners

Qiming Venture Partners

Asia, Shanghai, China, Shanghai

Co-Investments: 2

Hankang Capital

Asia, Shanghai, China, Shanghai

Co-Investments: 1

Vivo Capital

North America, California, United States, Palo Alto

Co-Investments: 2

Lilly Asia Ventures

Lilly Asia Ventures

Asia, Shanghai, China, Shanghai

Co-Investments: 4

What are some of recent deals done by Janchor Partners?

FPL Technologies

Pune, Maharashtra, India

FPL is on a mission to re-imagine credit and payments from first principles and is building a mobile-first credit card.

Credit CardsFinanceFinancial ServicesFinTech

Series CDec 30, 2021

Amount Raised: $75,000,000

Abbisko Therapeutics

Shanghai, Shanghai, China

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.

Health CarePharmaceuticalTherapeutics

Series DJan 7, 2021

Amount Raised: $123,000,000

Shanghai, Shanghai, China

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

BiopharmaBiotechnologyPharmaceutical

Series DSep 27, 2020

Amount Raised: $147,000,000

Everest Medicines

New York, New York, United States

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

BiotechnologyHealth CarePharmaceutical

Series CJun 3, 2020

Amount Raised: $310,000,000

Yantai, Liaoning, China

Remegen is a biotech company focused on discovering and developing a new generation of targeted therapies for the treatments of cancer.

BiotechnologyHealth CareTherapeutics

Private EquityMar 17, 2020

Amount Raised: $100,000,000

Rongchang Pharmaceutical

Yantai, Liaoning, China

Rongchang Pharmaceutical is a health care Company.

Health CareMedicalPharmaceutical

Series AMar 16, 2020